Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desmopressin for Nocturnal Enuresis After Radical Cystectomy
NCT01582542Phase 4Unknown
- Sponsor
- Rabin Medical Center
- Start
- Apr 2012
- Primary completion
- Dec 2013
- Modality
- Inhalation Devices
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of desmopressin in nocturnal enuresis (NE), sponsored by Rabin Medical Center. Primary endpoint: Rate of improvement in Nocturnal incontinence at 1 month. Status: unknown.
02
Drugs
desmopressin
03
Conditions
nocturnal enuresis (NE)
Beyond the preview
Go deeper on NCT01582542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01582542.